Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6758
Source ID: NCT00952445
Associated Drug: T0903131 Besylate
Title: A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type II
Interventions: DRUG: T0903131 Besylate|DRUG: Placebo
Outcome Measures:
Sponsor/Collaborators: Sponsor: InteKrin Therapeutics, Inc.
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 70
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2003-12
Completion Date: 2004-06
Results First Posted:
Last Update Posted: 2022-10-19
Locations: Whittier Diabetes Institute, La Jolla, California, United States|Charles R. Drew University, Los Angeles, California, United States|National Research Institute, Los Angeles, California, United States|Lovelace Research Institute, Santa Ana, California, United States|University of Miami, Miami, Florida, United States|GFI Research Center, Evansville, Indiana, United States|Joslin Diabetes Center, Boston, Massachusetts, United States|Radiant Research, Edina, Minnesota, United States|Radiant Research, Saint Louis, Missouri, United States|St Louis Center for Clinical Research, Saint Louis, Missouri, United States|Kaleida Health Diabetes Center, Buffalo, New York, United States|Rochester Clinical Research, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Radiant Research, Portland, Oregon, United States|Radiant Research, Anderson, South Carolina, United States|Baylor University Endocrine Center, Dallas, Texas, United States|Dallas Diabetes and Endocrine Research Center, Dallas, Texas, United States|Endocrine Associates of Dallas, Dallas, Texas, United States|Diabetes and Grandular Disease Clinic and Reseach Center, San Antonio, Texas, United States|Endocrine Research Specialists, Ogden, Utah, United States|Salem VA Medical Center, Salem, Virginia, United States
URL: https://clinicaltrials.gov/show/NCT00952445

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress